Beta
401396

In vitro Myco-Synthesized copper oxide nanoparticles: a promising antiviral agent with antioxidant, anti-inflammatory, and anti-cancer activity

Article

Last updated: 07 Jan 2025

Subjects

-

Tags

Microbial Nanoparticles

Abstract

The most suitable approach for manufacturing different metal and metal oxide nanoparticles is to use fungi. The purpose of this work is to examine how fungi that have been isolated from soil produce CuO-nanoparticles (CuO-NPs). It has been demonstrated that Aspergillus niger (A. niger), which was obtained from soil and recognized using both conventional and molecular methods, is capable of producing CuO- nanoparticles. UV, XRD, FITR, and TEM have all been used to characterize these nanoparticles. The antioxidant potential of synthesized CuO-nanoparticles was examined by the process of DPPH scavenging. Red blood cells' membrane stabilization technique was used to investigate the anti-inflammatory properties. The MTT procedure was utilized to explore the anticancer activity. The antiviral was identified by the decrease in the ability of Coxsackie-B, Adenovirus-22, and Adenovirus-40 to infect Vero Cells. CuO nanoparticles have a spherical form, a peak at 345 nm, and diameters in a range from 4 to 18 nm. Using the DPPH technique, the biosynthesized CuO-NPs were found to have antioxidant action, with an IC50 value of 27.93±2.4 µg/mL. The anti-inflammatory proportion of the biosynthesized CuO-NPs was 98.6% at 1000 µg/mL and dropped to 48.9% at 100 µg/mL. The biosynthesized CuO-NPs exhibited anticancer action versus MCF-7, PANC1, and Caco2 cells, with IC50 values of 82.02 ± 1.04 µg/mL, 91.45 ± 1.89, and 151.45 ± 0.89, respectively. Ascending concentrations of CuO-NPs enhanced their antiviral effect (%) against the Co-B4, Adeno-22 and Adeno-40 viruses. The myco-synthesized CuO-NPs showed encouraging results and have the potential to be utilized in a range of therapeutic uses.

DOI

10.21608/mb.2024.317736.1167

Keywords

Adenovirus-22, Adenovirus-40, Coxsackie-B, Fitr, TEM, UV, XRD

Authors

First Name

Alaa

Last Name

Abd-Elhameed

MiddleName

Youssef

Affiliation

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, 71524 Assiut, Egypt.

Email

alaayousif22@yahoo.com

City

-

Orcid

-

First Name

Ahmed

Last Name

Eladly

MiddleName

Mohammed

Affiliation

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, 71524 Assiut, Egypt.

Email

ahmedeladly.ast@azhar.edu.eg

City

-

Orcid

-

First Name

Ahmed

Last Name

Abdel-radi

MiddleName

Wardany

Affiliation

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, 71524 Assiut, Egypt.

Email

ahmed_wr2000@azhar.edu.eg

City

-

Orcid

-

First Name

Alsayed

Last Name

Mekky

MiddleName

E.

Affiliation

Botany and Microbiology Department, Faculty of Science, Al-Azhar University, Nasr City 11884, Cairo, Egypt.

Email

alsayedessam@azhar.edu.eg

City

-

Orcid

-

Volume

9

Article Issue

2

Related Issue

49870

Issue Date

2024-12-01

Receive Date

2024-09-02

Publish Date

2024-12-30

Print ISSN

2357-0326

Online ISSN

2357-0334

Link

https://mb.journals.ekb.eg/article_401396.html

Detail API

http://journals.ekb.eg?_action=service&article_code=401396

Order

401,396

Type

Original Article

Type Code

502

Publication Type

Journal

Publication Title

Microbial Biosystems

Publication Link

https://mb.journals.ekb.eg/

MainTitle

In vitro Myco-Synthesized copper oxide nanoparticles: a promising antiviral agent with antioxidant, anti-inflammatory, and anti-cancer activity

Details

Type

Article

Created At

07 Jan 2025